Guldager, Casper H.
Mølgaard, Jesper
Hansen, Helle K.
Meyhoff, Christian S.
Aasvang, Eske K.
Funding for this research was provided by:
National Hospital
Article History
Received: 24 September 2025
Accepted: 6 July 2026
First Online: 11 July 2026
Declarations
Competing interests: CSM and EKA have founded a start-up company, WARD24/7 ApS, with the aim of pursuing the regulatory and commercial activities of the WARD-project (Wireless Assessment of Respiratory and circulatory Distress, a project developing a clinical support system for continuous wireless monitoring of vital signs). WARD24/7 ApS has obtained license agreement for any WARD-project software and patents. One patent has been filed: “Wireless Assessment of Respiratory and circulatory Distress (WARD), EP 21184712.4 and EP 21205557.8”.